What is the recommended treatment for a patient presenting with typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Typhoid Fever

Azithromycin 500 mg once daily for 7-14 days is the preferred first-line treatment for adults with typhoid fever, particularly given widespread fluoroquinolone resistance exceeding 70% in endemic regions. 1, 2

First-Line Treatment Algorithm

For Adults

  • Start azithromycin 500 mg orally once daily for 7-14 days as empiric therapy, especially for cases originating from South Asia where fluoroquinolone resistance approaches 96% 1, 2
  • Obtain blood cultures before initiating antibiotics when possible, as they have the highest yield (40-80% sensitivity) within the first week of symptoms 3, 4

For Children

  • Azithromycin 20 mg/kg/day (maximum 1g/day) for 7-14 days is the recommended pediatric dose 1, 2

For Severely Ill or Unstable Patients

  • Ceftriaxone 2g IV daily for 14 days should be used when the patient's clinical condition is unstable or they cannot tolerate oral therapy 3, 4
  • All isolates reported to surveillance systems remain sensitive to ceftriaxone 3

Why Azithromycin Over Other Options

Azithromycin demonstrates superior clinical outcomes:

  • Lower risk of treatment failure (OR 0.48) compared to fluoroquinolones 1, 2
  • Hospital stays approximately 1 day shorter (mean difference -1.04 days) 1, 2
  • Dramatically lower relapse risk (OR 0.09) compared to ceftriaxone 1, 2
  • Resistance to azithromycin remains rare in most regions 3, 4

Fluoroquinolones should be avoided empirically because resistance exceeds 70% in isolates imported from Asia, with some regions approaching 96% resistance 3, 1, 2

Critical Pitfalls to Avoid

Never Use Ciprofloxacin Empirically for Travel-Associated Cases

  • More than 70% of S. typhi and S. paratyphi isolates from South/Southeast Asia are fluoroquinolone-resistant 3, 1, 2
  • Ciprofloxacin disc testing alone is unreliable for determining true fluoroquinolone sensitivity 3, 4
  • The organism must also be sensitive to nalidixic acid on disc testing to be considered truly fluoroquinolone-sensitive 3, 4

Avoid Cefixime as First-Line Therapy

  • Cefixime has documented treatment failure rates of 4-37.6% 3, 5
  • If cefixime must be used, mandatory test-of-cure at 1 week is required 1
  • Clinical failure may be increased 13-fold compared to fluoroquinolones (RR 13.39,95% CI 3.24-55.39) 5

Complete the Full Antibiotic Course

  • Do not discontinue antibiotics prematurely even if fever resolves early 1, 2
  • Relapse occurs in 10-15% of inadequately treated cases 1, 2, 4
  • Treatment should be continued for the full 7-14 days to reduce relapse risk 3, 1

Expected Clinical Response and Monitoring

Fever Clearance Timeline

  • Expect fever clearance within 4-5 days of appropriate antibiotic therapy 1, 2, 4
  • If no clinical response by day 5, consider antimicrobial resistance or alternative diagnosis 2
  • Mean defervescence time with ceftriaxone is approximately 4 days when complications are excluded 6

Common Adverse Effects of Azithromycin

  • Monitor for gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 1, 2
  • Watch for potential drug interactions with QT-prolonging medications 1, 2

Management of Complications

Intestinal Perforation

  • Occurs in 10-15% of patients when illness duration exceeds 2 weeks 1, 2, 4
  • Requires immediate surgical intervention with simple excision and closure 1, 2
  • Surgical success rates reach up to 88.2% 1, 2

Other Severe Complications

  • Gastrointestinal bleeding and typhoid encephalopathy can occur in 10-15% of patients 4
  • Life-threatening complications typically arise in the second week of untreated illness 7

Alternative Treatment Options When Susceptibility is Confirmed

Fluoroquinolones (Only for Susceptible Isolates)

  • Ciprofloxacin remains effective when susceptibility is confirmed, with fever clearance time <4 days, cure rates >96%, and relapse rates <8% 3, 7
  • However, ciprofloxacin is FDA-approved for typhoid fever but should only be used when local resistance patterns support its use 8
  • Ofloxacin and enoxacin achieved 100% cure rates without relapse in older studies 9

Ceftriaxone Dosing Details

  • Adults: 2g IV daily for 14 days 4
  • Children: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days, though 14 days reduces relapse 2, 6, 10
  • Higher doses (not less than 3g once daily) or longer duration may be needed to reduce relapse incidence 9

Prevention Strategies

Vaccination Recommendations

  • Typhoid vaccination is recommended for travelers to endemic areas (Latin America, Asia, Africa) with moderate to high risk of exposure 1, 2, 4
  • Two vaccines available in the United States: Ty21a oral vaccine and Vi-polysaccharide parenteral vaccine 1

Important Vaccination Limitations

  • Vaccination provides only 50-80% protection 1, 2, 4
  • Does not protect against Salmonella Paratyphi 1, 2, 4
  • Hand hygiene and food/water safety precautions remain essential and should not be replaced by vaccination alone 1, 2, 4

References

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Typhoid Fever Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Research

Ceftriaxone therapy in bacteremic typhoid fever.

Antimicrobial agents and chemotherapy, 1985

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Research

Antibiotic therapy for typhoid fever.

Chemotherapy, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.